Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Kiora Pharmaceuticals Inc. (KPRX)

Kiora Pharmaceuticals Inc. (KPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Kiora Pharmaceuticals Inc. 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 USA

www.kiorapharma.com P: 858-224-9600

Description:

Kiora Pharmaceuticals Inc. is a clinical-stage specialty pharmaceutical company. It involved in developing and commercializing products for treating ophthalmic diseases. The company's product pipeline includes KIO-301, KIO-101 and KIO-201. Kiora Pharmaceuticals Inc., formerly known as EyeGate Pharmaceuticals Inc., is based in SALT LAKE CITY.

Key Statistics

Overview:

Market Capitalization, $K 12,340
Enterprise Value, $K 9,890
Shares Outstanding, K 26,256
Annual Sales, $ 0 K
Annual Net Income, $ -12,510 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,740 K
EBIT, $ -12,590 K
EBITDA, $ -12,540 K
60-Month Beta -0.26
% of Insider Shareholders 0.94%
% of Institutional Shareholders 76.97%
Float, K 26,009
% Float 99.06%
Short Volume Ratio 0.53

Growth:

1-Year Return -89.27%
3-Year Return -99.72%
5-Year Return -99.71%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 98.50%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.89 on 11/09/23
Latest Earnings Date 05/14/24
Earnings Per Share ttm -2.68
EPS Growth vs. Prev Qtr -12.66%
EPS Growth vs. Prev Year 79.54%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-40 on 09/27/22

KPRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -131.68%
Return-on-Assets % -75.82%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.64
Book Value/Share 0.79
Interest Coverage -1,241.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar